XNASFORA
Market cap63mUSD
Dec 24, Last price
2.05USD
1D
0.49%
1Q
-4.65%
Jan 2017
-98.72%
IPO
-86.87%
Name
Forian Inc
Chart & Performance
P/E
5.72
P/S
3.10
EPS
0.36
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
%
Revenues
20m
-26.87%
Net income
11m
P
CFO
729k
P
Earnings
Mar 26, 2025
Profile
Forian Inc. provides software solutions, proprietary data driven insights, and predictive analytics to optimize the operational, clinical, and financial performance of its healthcare, cannabis, and government customers. It operates through three segments: Information & Software, Services, and Other. The company's products include BioTrack, a vertically integrated point of sale, manufacturing, delivery, and cultivator software solution for dispensaries, cultivators, manufacturers, and distributors; and Cannalytics, a Software as a Service based analytics solution that provides clients with a presentation of business performance. Its products also comprise BioTrack seed-to-sale compliance traceability platform, which is used to manage the tracking and tracing of various cannabis products from cultivation to sale; BioTrack State Traceability & Enforcement Monitoring System to ensure transparency and accountability throughout cannabis supply chain; and STEMS, a seed-to-sale tracking module, to provide cannabis program management solution to cannabis regulatory agencies. In addition, the company offers security monitoring and web marketing services. The company is headquartered in Newtown, Pennsylvania.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | |||||
Revenues | 20,481 -26.87% | 28,006 65.91% | 16,880 2,997.93% | ||
Cost of revenue | 25,402 | 45,622 | 41,299 | ||
Unusual Expense (Income) | |||||
NOPBT | (4,921) | (17,616) | (24,420) | ||
NOPBT Margin | |||||
Operating Taxes | 86 | 24 | 23 | ||
Tax Rate | |||||
NOPAT | (5,006) | (17,640) | (24,442) | ||
Net income | 11,107 -142.76% | (25,972) -2.18% | (26,551) 433.52% | ||
Dividends | |||||
Dividend yield | |||||
Proceeds from repurchase of equity | (3,450) | (87) | 11,969 | ||
BB yield | 3.66% | 0.10% | -4.18% | ||
| Debt | |||||
Debt current | 21 | 265 | 260 | ||
Long-term debt | 24,881 | 26,125 | 25,731 | ||
Deferred revenue | (1,625) | ||||
Other long-term liabilities | 1,000 | 1,497 | |||
Net debt | (23,437) | 5,802 | (5,072) | ||
| Cash flow | |||||
Cash from operating activities | 729 | (8,776) | (17,258) | ||
CAPEX | (75) | (1,711) | (1,443) | ||
Cash from investing activities | 7,120 | (6,461) | (1,025) | ||
Cash from financing activities | (4,602) | (101) | 36,281 | ||
FCF | (4,003) | (18,460) | (26,787) | ||
| Balance | |||||
Cash | 48,340 | 20,716 | 31,063 | ||
Long term investments | (127) | ||||
Excess cash | 47,316 | 19,189 | 30,219 | ||
Stockholders' equity | (47,654) | (58,760) | (32,788) | ||
Invested Capital | 99,726 | 96,804 | 83,092 | ||
ROIC | |||||
ROCE | |||||
| EV | |||||
Common stock shares outstanding | 32,231 | 32,031 | 31,773 | ||
Price | 2.93 7.14% | 2.73 -69.73% | 9.02 -7.96% | ||
Market cap | 94,275 7.81% | 87,445 -69.49% | 286,594 -1.95% | ||
EV | 70,838 | 93,246 | 281,522 | ||
EBITDA | (4,824) | (14,460) | (22,210) | ||
EV/EBITDA | |||||
Interest | 835 | 873 | 322 | ||
Interest/NOPBT | |||||